Welcome to LookChem.com Sign In|Join Free
  • or
N4-(3-bromophenyl)-6-chloropyrimidine-4,5-diamine is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

833451-03-9

Post Buying Request

833451-03-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

833451-03-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 833451-03-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,3,4,5 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 833451-03:
(8*8)+(7*3)+(6*3)+(5*4)+(4*5)+(3*1)+(2*0)+(1*3)=149
149 % 10 = 9
So 833451-03-9 is a valid CAS Registry Number.

833451-03-9Relevant academic research and scientific papers

An efficient synthesis of 4,6-substituted pyrrolo[3,2-d]pyrimidines by silver-catalyzed cyclization of acetylene amine

Xie, Rui,Hu, Ying,Wan, Huixin,Hu, Yanwei,Chen, Shaohua,Zhang, Shilei,Zhang, Yinan

supporting information, p. 2418 - 2421 (2016/05/19)

A silver catalyzed cyclization of acetylene amine was developed to synthesize 4,6-substituted pyrrolo[3,2-d]pyrimidine, a bioactive isosteric scaffold of purine. Starting from simple commercially available acetylenes and pyrimidines, the method was found

Tricyclic azepine derivatives: Pyrimido[4,5-b]-1,4-benzoxazepines as a novel class of epidermal growth factor receptor kinase inhibitors

Smith II, Leon,Piatnitski, Evgueni L.,Kiselyov, Alexander S.,Ouyang, Xiaohu,Chen, Xiaoling,Burdzovic-Wizemann, Sabina,Xu, Yongjiang,Wang, Ying,Rosler, Robin L.,Patel, Sheetal N.,Chiang, Hui-Hsien,Milligan, Daniel L.,Columbus, John,Wong, Wai C.,Doody, Jacqueline F.,Hadari, Yaron R.

, p. 1643 - 1646 (2007/10/03)

A novel class of pyrimido[4,5-b]-1,4-benzoxazepines is described as inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase. Two compounds display potent EGFR inhibitory activity of less than 1 μM in cellular phosphorylation assays (IC50 0.47-0.69 μM) and are highly selective against a small kinase panel. Such compounds demonstrate anti-EGFR activity within a class that is different from any known EGFR inhibitor scaffolds. They also provide a basis for the design of kinase inhibitors with the desired selectivity profile.

Novel tricyclic azepine derivatives: Biological evaluation of pyrimido[4,5-b]-1,4-benzoxazepines, thiazepines, and diazepines as inhibitors of the epidermal growth factor receptor tyrosine kinase

Smith II, Leon,Wong, Wai C.,Kiselyov, Alexander S.,Burdzovic-Wizemann, Sabina,Mao, Yunyu,Xu, Yongjiang,Duncton, Matthew A.J.,Kim, Ki,Piatnitski, Evgueni L.,Doody, Jacqueline F.,Wang, Ying,Rosler, Robin L.,Milligan, Daniel,Columbus, John,Balagtas, Chris,Lee, Sui Ping,Konovalov, Andrey,Hadari, Yaron R.

, p. 5102 - 5106 (2007/10/03)

Novel tricyclic derivatives containing an oxazepine, thiazepine, or diazepine ring were studied for their EGFR tyrosine kinase inhibitory activity. While the oxazepines were in general more potent than thiazepines, the diazepines displayed somewhat differ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 833451-03-9